Reversibility of graft rejection following a short cyclosporin-A administration 5 days after grafting.
The aim of this research was to investigate whether cyclosporin-A (Cy-A) could exert its action on graft rejection in progress. For this purpose, heart-lung grafting was performed in a strong histoincompatible combination of rats (BN/LEW). In one group of animals, Cy-A was administered at the dose of 15 mg/kg daily for 10 days starting on the 5th day after grafting. In a control group only olive oil was administered. Five of six animals treated with Cy-A showed a graft survival over 4 weeks and in two cases it was over 2 months when they were killed.